• レポートコード:QYR2104Z5751 • 出版社/出版日:QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態:英文、PDF、130ページ • 納品方法:Eメール(納期:3日) • 産業分類:医療 |
Single User | ¥546,000 (USD3,900) | ▷ お問い合わせ |
Multi User/Five User | ¥819,000 (USD5,850) | ▷ お問い合わせ |
Enterprise License(同一法人内共有可) | ¥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査資料では、結核診断・治療のグローバル市場(2016年~2027年)について調べ、市場動向、主要企業の市場シェア、種類別市場規模(臨床検査、核酸検査、マントー検査、X線撮影、薬剤感受性検査)、用途別市場規模(病院、政府機関、個人)、主要地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、関連企業情報などを掲載しています。 ・市場概要 ・結核診断・治療の市場動向 ・企業の競争状況、市場シェア ・結核診断・治療の種類別市場規模(臨床検査、核酸検査、マントー検査、X線撮影、薬剤感受性検査) ・結核診断・治療の用途別市場規模(病院、政府機関、個人) ・結核診断・治療の北米市場規模2016-2027(アメリカ、カナダ) ・結核診断・治療のヨーロッパ市場規模2016-2027(ドイツ、フランス、イギリス等) ・結核診断・治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等) ・結核診断・治療の中南米市場規模2016-2027(メキシコ、ブラジル) ・結核診断・治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等) ・主要企業情報(Abbott Laboratories、Akonni Biosystems、Thermo Fisher Scientific、BD、Bio-Synth、bioMérieux、Cepheid、Eiken Chemical、Epistem、Roche、GSK、Hain Lifesciences、Hologic、Labatec、Lupin、Otsuka Novel Products、QIAGEN、Sandoz、Sanofi) ・結論 |
Market Analysis and Insights: Global Tuberculosis Diagnosis and Treatment Market
The global Tuberculosis Diagnosis and Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Tuberculosis Diagnosis and Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Tuberculosis Diagnosis and Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Tuberculosis Diagnosis and Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Tuberculosis Diagnosis and Treatment market.
Global Tuberculosis Diagnosis and Treatment Scope and Market Size
Tuberculosis Diagnosis and Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Tuberculosis Diagnosis and Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Laboratory Testing
Nucleic Acid Tests
Mantoux Test
Radiography
Drug Susceptibility Test
Segment by Application
Hospitals
Government organizations
Individual
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott Laboratories
Akonni Biosystems
Thermo Fisher Scientific
BD
Bio-Synth
bioMérieux
Cepheid
Eiken Chemical
Epistem
BD
Bio-Synth
Hain Lifesciences
Hologic
Labatec
Lupin
Otsuka Novel Products
QIAGEN
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tuberculosis Diagnosis and Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Laboratory Testing
1.2.3 Nucleic Acid Tests
1.2.4 Mantoux Test
1.2.5 Radiography
1.2.6 Drug Susceptibility Test
1.3 Market by Application
1.3.1 Global Tuberculosis Diagnosis and Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Government organizations
1.3.4 Individual
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Tuberculosis Diagnosis and Treatment Market Perspective (2016-2027)
2.2 Tuberculosis Diagnosis and Treatment Growth Trends by Regions
2.2.1 Tuberculosis Diagnosis and Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Tuberculosis Diagnosis and Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Tuberculosis Diagnosis and Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Tuberculosis Diagnosis and Treatment Industry Dynamic
2.3.1 Tuberculosis Diagnosis and Treatment Market Trends
2.3.2 Tuberculosis Diagnosis and Treatment Market Drivers
2.3.3 Tuberculosis Diagnosis and Treatment Market Challenges
2.3.4 Tuberculosis Diagnosis and Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tuberculosis Diagnosis and Treatment Players by Revenue
3.1.1 Global Top Tuberculosis Diagnosis and Treatment Players by Revenue (2016-2021)
3.1.2 Global Tuberculosis Diagnosis and Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Tuberculosis Diagnosis and Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Tuberculosis Diagnosis and Treatment Revenue
3.4 Global Tuberculosis Diagnosis and Treatment Market Concentration Ratio
3.4.1 Global Tuberculosis Diagnosis and Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tuberculosis Diagnosis and Treatment Revenue in 2020
3.5 Tuberculosis Diagnosis and Treatment Key Players Head office and Area Served
3.6 Key Players Tuberculosis Diagnosis and Treatment Product Solution and Service
3.7 Date of Enter into Tuberculosis Diagnosis and Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tuberculosis Diagnosis and Treatment Breakdown Data by Type
4.1 Global Tuberculosis Diagnosis and Treatment Historic Market Size by Type (2016-2021)
4.2 Global Tuberculosis Diagnosis and Treatment Forecasted Market Size by Type (2022-2027)
5 Tuberculosis Diagnosis and Treatment Breakdown Data by Application
5.1 Global Tuberculosis Diagnosis and Treatment Historic Market Size by Application (2016-2021)
5.2 Global Tuberculosis Diagnosis and Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Tuberculosis Diagnosis and Treatment Market Size (2016-2027)
6.2 North America Tuberculosis Diagnosis and Treatment Market Size by Type
6.2.1 North America Tuberculosis Diagnosis and Treatment Market Size by Type (2016-2021)
6.2.2 North America Tuberculosis Diagnosis and Treatment Market Size by Type (2022-2027)
6.2.3 North America Tuberculosis Diagnosis and Treatment Market Size by Type (2016-2027)
6.3 North America Tuberculosis Diagnosis and Treatment Market Size by Application
6.3.1 North America Tuberculosis Diagnosis and Treatment Market Size by Application (2016-2021)
6.3.2 North America Tuberculosis Diagnosis and Treatment Market Size by Application (2022-2027)
6.3.3 North America Tuberculosis Diagnosis and Treatment Market Size by Application (2016-2027)
6.4 North America Tuberculosis Diagnosis and Treatment Market Size by Country
6.4.1 North America Tuberculosis Diagnosis and Treatment Market Size by Country (2016-2021)
6.4.2 North America Tuberculosis Diagnosis and Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Tuberculosis Diagnosis and Treatment Market Size (2016-2027)
7.2 Europe Tuberculosis Diagnosis and Treatment Market Size by Type
7.2.1 Europe Tuberculosis Diagnosis and Treatment Market Size by Type (2016-2021)
7.2.2 Europe Tuberculosis Diagnosis and Treatment Market Size by Type (2022-2027)
7.2.3 Europe Tuberculosis Diagnosis and Treatment Market Size by Type (2016-2027)
7.3 Europe Tuberculosis Diagnosis and Treatment Market Size by Application
7.3.1 Europe Tuberculosis Diagnosis and Treatment Market Size by Application (2016-2021)
7.3.2 Europe Tuberculosis Diagnosis and Treatment Market Size by Application (2022-2027)
7.3.3 Europe Tuberculosis Diagnosis and Treatment Market Size by Application (2016-2027)
7.4 Europe Tuberculosis Diagnosis and Treatment Market Size by Country
7.4.1 Europe Tuberculosis Diagnosis and Treatment Market Size by Country (2016-2021)
7.4.2 Europe Tuberculosis Diagnosis and Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Tuberculosis Diagnosis and Treatment Market Size (2016-2027)
8.2 Asia-Pacific Tuberculosis Diagnosis and Treatment Market Size by Type
8.2.1 Asia-Pacific Tuberculosis Diagnosis and Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Tuberculosis Diagnosis and Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Tuberculosis Diagnosis and Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Tuberculosis Diagnosis and Treatment Market Size by Application
8.3.1 Asia-Pacific Tuberculosis Diagnosis and Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Tuberculosis Diagnosis and Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Tuberculosis Diagnosis and Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Tuberculosis Diagnosis and Treatment Market Size by Region
8.4.1 Asia-Pacific Tuberculosis Diagnosis and Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Tuberculosis Diagnosis and Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Tuberculosis Diagnosis and Treatment Market Size (2016-2027)
9.2 Latin America Tuberculosis Diagnosis and Treatment Market Size by Type
9.2.1 Latin America Tuberculosis Diagnosis and Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Tuberculosis Diagnosis and Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Tuberculosis Diagnosis and Treatment Market Size by Type (2016-2027)
9.3 Latin America Tuberculosis Diagnosis and Treatment Market Size by Application
9.3.1 Latin America Tuberculosis Diagnosis and Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Tuberculosis Diagnosis and Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Tuberculosis Diagnosis and Treatment Market Size by Application (2016-2027)
9.4 Latin America Tuberculosis Diagnosis and Treatment Market Size by Country
9.4.1 Latin America Tuberculosis Diagnosis and Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Tuberculosis Diagnosis and Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tuberculosis Diagnosis and Treatment Market Size (2016-2027)
10.2 Middle East & Africa Tuberculosis Diagnosis and Treatment Market Size by Type
10.2.1 Middle East & Africa Tuberculosis Diagnosis and Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Tuberculosis Diagnosis and Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Tuberculosis Diagnosis and Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Tuberculosis Diagnosis and Treatment Market Size by Application
10.3.1 Middle East & Africa Tuberculosis Diagnosis and Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Tuberculosis Diagnosis and Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Tuberculosis Diagnosis and Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Tuberculosis Diagnosis and Treatment Market Size by Country
10.4.1 Middle East & Africa Tuberculosis Diagnosis and Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Tuberculosis Diagnosis and Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Tuberculosis Diagnosis and Treatment Introduction
11.1.4 Abbott Laboratories Revenue in Tuberculosis Diagnosis and Treatment Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 Akonni Biosystems
11.2.1 Akonni Biosystems Company Details
11.2.2 Akonni Biosystems Business Overview
11.2.3 Akonni Biosystems Tuberculosis Diagnosis and Treatment Introduction
11.2.4 Akonni Biosystems Revenue in Tuberculosis Diagnosis and Treatment Business (2016-2021)
11.2.5 Akonni Biosystems Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Details
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Tuberculosis Diagnosis and Treatment Introduction
11.3.4 Thermo Fisher Scientific Revenue in Tuberculosis Diagnosis and Treatment Business (2016-2021)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 BD
11.4.1 BD Company Details
11.4.2 BD Business Overview
11.4.3 BD Tuberculosis Diagnosis and Treatment Introduction
11.4.4 BD Revenue in Tuberculosis Diagnosis and Treatment Business (2016-2021)
11.4.5 BD Recent Development
11.5 Bio-Synth
11.5.1 Bio-Synth Company Details
11.5.2 Bio-Synth Business Overview
11.5.3 Bio-Synth Tuberculosis Diagnosis and Treatment Introduction
11.5.4 Bio-Synth Revenue in Tuberculosis Diagnosis and Treatment Business (2016-2021)
11.5.5 Bio-Synth Recent Development
11.6 bioMérieux
11.6.1 bioMérieux Company Details
11.6.2 bioMérieux Business Overview
11.6.3 bioMérieux Tuberculosis Diagnosis and Treatment Introduction
11.6.4 bioMérieux Revenue in Tuberculosis Diagnosis and Treatment Business (2016-2021)
11.6.5 bioMérieux Recent Development
11.7 Cepheid
11.7.1 Cepheid Company Details
11.7.2 Cepheid Business Overview
11.7.3 Cepheid Tuberculosis Diagnosis and Treatment Introduction
11.7.4 Cepheid Revenue in Tuberculosis Diagnosis and Treatment Business (2016-2021)
11.7.5 Cepheid Recent Development
11.8 Eiken Chemical
11.8.1 Eiken Chemical Company Details
11.8.2 Eiken Chemical Business Overview
11.8.3 Eiken Chemical Tuberculosis Diagnosis and Treatment Introduction
11.8.4 Eiken Chemical Revenue in Tuberculosis Diagnosis and Treatment Business (2016-2021)
11.8.5 Eiken Chemical Recent Development
11.9 Epistem
11.9.1 Epistem Company Details
11.9.2 Epistem Business Overview
11.9.3 Epistem Tuberculosis Diagnosis and Treatment Introduction
11.9.4 Epistem Revenue in Tuberculosis Diagnosis and Treatment Business (2016-2021)
11.9.5 Epistem Recent Development
11.10 Roche
11.10.1 Roche Company Details
11.10.2 Roche Business Overview
11.10.3 Roche Tuberculosis Diagnosis and Treatment Introduction
11.10.4 Roche Revenue in Tuberculosis Diagnosis and Treatment Business (2016-2021)
11.10.5 Roche Recent Development
11.11 GSK
11.11.1 GSK Company Details
11.11.2 GSK Business Overview
11.11.3 GSK Tuberculosis Diagnosis and Treatment Introduction
11.11.4 GSK Revenue in Tuberculosis Diagnosis and Treatment Business (2016-2021)
11.11.5 GSK Recent Development
11.12 Hain Lifesciences
11.12.1 Hain Lifesciences Company Details
11.12.2 Hain Lifesciences Business Overview
11.12.3 Hain Lifesciences Tuberculosis Diagnosis and Treatment Introduction
11.12.4 Hain Lifesciences Revenue in Tuberculosis Diagnosis and Treatment Business (2016-2021)
11.12.5 Hain Lifesciences Recent Development
11.13 Hologic
11.13.1 Hologic Company Details
11.13.2 Hologic Business Overview
11.13.3 Hologic Tuberculosis Diagnosis and Treatment Introduction
11.13.4 Hologic Revenue in Tuberculosis Diagnosis and Treatment Business (2016-2021)
11.13.5 Hologic Recent Development
11.14 Labatec
11.14.1 Labatec Company Details
11.14.2 Labatec Business Overview
11.14.3 Labatec Tuberculosis Diagnosis and Treatment Introduction
11.14.4 Labatec Revenue in Tuberculosis Diagnosis and Treatment Business (2016-2021)
11.14.5 Labatec Recent Development
11.15 Lupin
11.15.1 Lupin Company Details
11.15.2 Lupin Business Overview
11.15.3 Lupin Tuberculosis Diagnosis and Treatment Introduction
11.15.4 Lupin Revenue in Tuberculosis Diagnosis and Treatment Business (2016-2021)
11.15.5 Lupin Recent Development
11.16 Otsuka Novel Products
11.16.1 Otsuka Novel Products Company Details
11.16.2 Otsuka Novel Products Business Overview
11.16.3 Otsuka Novel Products Tuberculosis Diagnosis and Treatment Introduction
11.16.4 Otsuka Novel Products Revenue in Tuberculosis Diagnosis and Treatment Business (2016-2021)
11.16.5 Otsuka Novel Products Recent Development
11.17 QIAGEN
11.17.1 QIAGEN Company Details
11.17.2 QIAGEN Business Overview
11.17.3 QIAGEN Tuberculosis Diagnosis and Treatment Introduction
11.17.4 QIAGEN Revenue in Tuberculosis Diagnosis and Treatment Business (2016-2021)
11.17.5 QIAGEN Recent Development
11.18 Sandoz
11.18.1 Sandoz Company Details
11.18.2 Sandoz Business Overview
11.18.3 Sandoz Tuberculosis Diagnosis and Treatment Introduction
11.18.4 Sandoz Revenue in Tuberculosis Diagnosis and Treatment Business (2016-2021)
11.18.5 Sandoz Recent Development
11.18 Sanofi
.1 Sanofi Company Details
.2 Sanofi Business Overview
.3 Sanofi Tuberculosis Diagnosis and Treatment Introduction
.4 Sanofi Revenue in Tuberculosis Diagnosis and Treatment Business (2016-2021)
.5 Sanofi Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Tuberculosis Diagnosis and Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Laboratory Testing
Table 3. Key Players of Nucleic Acid Tests
Table 4. Key Players of Mantoux Test
Table 5. Key Players of Radiography
Table 6. Key Players of Drug Susceptibility Test
Table 7. Global Tuberculosis Diagnosis and Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Tuberculosis Diagnosis and Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Tuberculosis Diagnosis and Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Tuberculosis Diagnosis and Treatment Market Share by Regions (2016-2021)
Table 11. Global Tuberculosis Diagnosis and Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Tuberculosis Diagnosis and Treatment Market Share by Regions (2022-2027)
Table 13. Tuberculosis Diagnosis and Treatment Market Trends
Table 14. Tuberculosis Diagnosis and Treatment Market Drivers
Table 15. Tuberculosis Diagnosis and Treatment Market Challenges
Table 16. Tuberculosis Diagnosis and Treatment Market Restraints
Table 17. Global Tuberculosis Diagnosis and Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Tuberculosis Diagnosis and Treatment Market Share by Players (2016-2021)
Table 19. Global Top Tuberculosis Diagnosis and Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tuberculosis Diagnosis and Treatment as of 2020)
Table 20. Ranking of Global Top Tuberculosis Diagnosis and Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Tuberculosis Diagnosis and Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Tuberculosis Diagnosis and Treatment Product Solution and Service
Table 24. Date of Enter into Tuberculosis Diagnosis and Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Tuberculosis Diagnosis and Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Tuberculosis Diagnosis and Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global Tuberculosis Diagnosis and Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Tuberculosis Diagnosis and Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Tuberculosis Diagnosis and Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Tuberculosis Diagnosis and Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global Tuberculosis Diagnosis and Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Tuberculosis Diagnosis and Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Tuberculosis Diagnosis and Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Tuberculosis Diagnosis and Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Tuberculosis Diagnosis and Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Tuberculosis Diagnosis and Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Tuberculosis Diagnosis and Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Tuberculosis Diagnosis and Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Tuberculosis Diagnosis and Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Tuberculosis Diagnosis and Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Tuberculosis Diagnosis and Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Tuberculosis Diagnosis and Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Tuberculosis Diagnosis and Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Tuberculosis Diagnosis and Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Tuberculosis Diagnosis and Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Tuberculosis Diagnosis and Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Tuberculosis Diagnosis and Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Tuberculosis Diagnosis and Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Tuberculosis Diagnosis and Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Tuberculosis Diagnosis and Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Tuberculosis Diagnosis and Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Tuberculosis Diagnosis and Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Tuberculosis Diagnosis and Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Tuberculosis Diagnosis and Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Tuberculosis Diagnosis and Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Tuberculosis Diagnosis and Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Tuberculosis Diagnosis and Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Tuberculosis Diagnosis and Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Tuberculosis Diagnosis and Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Tuberculosis Diagnosis and Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Tuberculosis Diagnosis and Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Tuberculosis Diagnosis and Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. Abbott Laboratories Company Details
Table 65. Abbott Laboratories Business Overview
Table 66. Abbott Laboratories Tuberculosis Diagnosis and Treatment Product
Table 67. Abbott Laboratories Revenue in Tuberculosis Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 68. Abbott Laboratories Recent Development
Table 69. Akonni Biosystems Company Details
Table 70. Akonni Biosystems Business Overview
Table 71. Akonni Biosystems Tuberculosis Diagnosis and Treatment Product
Table 72. Akonni Biosystems Revenue in Tuberculosis Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 73. Akonni Biosystems Recent Development
Table 74. Thermo Fisher Scientific Company Details
Table 75. Thermo Fisher Scientific Business Overview
Table 76. Thermo Fisher Scientific Tuberculosis Diagnosis and Treatment Product
Table 77. Thermo Fisher Scientific Revenue in Tuberculosis Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 78. Thermo Fisher Scientific Recent Development
Table 79. BD Company Details
Table 80. BD Business Overview
Table 81. BD Tuberculosis Diagnosis and Treatment Product
Table 82. BD Revenue in Tuberculosis Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 83. BD Recent Development
Table 84. Bio-Synth Company Details
Table 85. Bio-Synth Business Overview
Table 86. Bio-Synth Tuberculosis Diagnosis and Treatment Product
Table 87. Bio-Synth Revenue in Tuberculosis Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 88. Bio-Synth Recent Development
Table 89. bioMérieux Company Details
Table 90. bioMérieux Business Overview
Table 91. bioMérieux Tuberculosis Diagnosis and Treatment Product
Table 92. bioMérieux Revenue in Tuberculosis Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 93. bioMérieux Recent Development
Table 94. Cepheid Company Details
Table 95. Cepheid Business Overview
Table 96. Cepheid Tuberculosis Diagnosis and Treatment Product
Table 97. Cepheid Revenue in Tuberculosis Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 98. Cepheid Recent Development
Table 99. Eiken Chemical Company Details
Table 100. Eiken Chemical Business Overview
Table 101. Eiken Chemical Revenue in Tuberculosis Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 102. Eiken Chemical Recent Development
Table 103. Epistem Company Details
Table 104. Epistem Business Overview
Table 105. Epistem Tuberculosis Diagnosis and Treatment Product
Table 106. Epistem Revenue in Tuberculosis Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 107. Epistem Recent Development
Table 108. Roche Company Details
Table 109. Roche Business Overview
Table 110. Roche Tuberculosis Diagnosis and Treatment Product
Table 111. Roche Revenue in Tuberculosis Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 112. Roche Recent Development
Table 113. GSK Company Details
Table 114. GSK Business Overview
Table 115. GSK Tuberculosis Diagnosis and Treatment Product
Table 116. GSK Revenue in Tuberculosis Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 117. GSK Recent Development
Table 118. Hain Lifesciences Company Details
Table 119. Hain Lifesciences Business Overview
Table 120. Hain Lifesciences Tuberculosis Diagnosis and Treatment Product
Table 121. Hain Lifesciences Revenue in Tuberculosis Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 122. Hain Lifesciences Recent Development
Table 123. Hologic Company Details
Table 124. Hologic Business Overview
Table 125. Hologic Tuberculosis Diagnosis and Treatment Product
Table 126. Hologic Revenue in Tuberculosis Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 127. Hologic Recent Development
Table 128. Labatec Company Details
Table 129. Labatec Business Overview
Table 130. Labatec Tuberculosis Diagnosis and Treatment Product
Table 131. Labatec Revenue in Tuberculosis Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 132. Labatec Recent Development
Table 133. Lupin Company Details
Table 134. Lupin Business Overview
Table 135. Lupin Tuberculosis Diagnosis and Treatment Product
Table 136. Lupin Revenue in Tuberculosis Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 137. Lupin Recent Development
Table 138. Otsuka Novel Products Company Details
Table 139. Otsuka Novel Products Business Overview
Table 140. Otsuka Novel Products Tuberculosis Diagnosis and Treatment Product
Table 141. Otsuka Novel Products Revenue in Tuberculosis Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 142. Otsuka Novel Products Recent Development
Table 143. QIAGEN Company Details
Table 144. QIAGEN Business Overview
Table 145. QIAGEN Tuberculosis Diagnosis and Treatment Product
Table 146. QIAGEN Revenue in Tuberculosis Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 147. QIAGEN Recent Development
Table 148. Sandoz Company Details
Table 149. Sandoz Business Overview
Table 150. Sandoz Tuberculosis Diagnosis and Treatment Product
Table 151. Sandoz Revenue in Tuberculosis Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 152. Sandoz Recent Development
Table 153. Sanofi Company Details
Table 154. Sanofi Business Overview
Table 155. Sanofi Tuberculosis Diagnosis and Treatment Product
Table 156. Sanofi Revenue in Tuberculosis Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 157. Sanofi Recent Development
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tuberculosis Diagnosis and Treatment Market Share by Type: 2020 VS 2027
Figure 2. Laboratory Testing Features
Figure 3. Nucleic Acid Tests Features
Figure 4. Mantoux Test Features
Figure 5. Radiography Features
Figure 6. Drug Susceptibility Test Features
Figure 7. Global Tuberculosis Diagnosis and Treatment Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Government organizations Case Studies
Figure 10. Individual Case Studies
Figure 11. Tuberculosis Diagnosis and Treatment Report Years Considered
Figure 12. Global Tuberculosis Diagnosis and Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Tuberculosis Diagnosis and Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Tuberculosis Diagnosis and Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Tuberculosis Diagnosis and Treatment Market Share by Regions (2022-2027)
Figure 16. Global Tuberculosis Diagnosis and Treatment Market Share by Players in 2020
Figure 17. Global Top Tuberculosis Diagnosis and Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tuberculosis Diagnosis and Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Tuberculosis Diagnosis and Treatment Revenue in 2020
Figure 19. Global Tuberculosis Diagnosis and Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Tuberculosis Diagnosis and Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Tuberculosis Diagnosis and Treatment Market Share by Type (2016-2027)
Figure 23. North America Tuberculosis Diagnosis and Treatment Market Share by Application (2016-2027)
Figure 24. North America Tuberculosis Diagnosis and Treatment Market Share by Country (2016-2027)
Figure 25. United States Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Tuberculosis Diagnosis and Treatment Market Share by Type (2016-2027)
Figure 29. Europe Tuberculosis Diagnosis and Treatment Market Share by Application (2016-2027)
Figure 30. Europe Tuberculosis Diagnosis and Treatment Market Share by Country (2016-2027)
Figure 31. Germany Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Tuberculosis Diagnosis and Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Tuberculosis Diagnosis and Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Tuberculosis Diagnosis and Treatment Market Share by Region (2016-2027)
Figure 41. China Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Tuberculosis Diagnosis and Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Tuberculosis Diagnosis and Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Tuberculosis Diagnosis and Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Tuberculosis Diagnosis and Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Tuberculosis Diagnosis and Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Tuberculosis Diagnosis and Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Abbott Laboratories Revenue Growth Rate in Tuberculosis Diagnosis and Treatment Business (2016-2021)
Figure 61. Akonni Biosystems Revenue Growth Rate in Tuberculosis Diagnosis and Treatment Business (2016-2021)
Figure 62. Thermo Fisher Scientific Revenue Growth Rate in Tuberculosis Diagnosis and Treatment Business (2016-2021)
Figure 63. BD Revenue Growth Rate in Tuberculosis Diagnosis and Treatment Business (2016-2021)
Figure 64. Bio-Synth Revenue Growth Rate in Tuberculosis Diagnosis and Treatment Business (2016-2021)
Figure 65. bioMérieux Revenue Growth Rate in Tuberculosis Diagnosis and Treatment Business (2016-2021)
Figure 66. Cepheid Revenue Growth Rate in Tuberculosis Diagnosis and Treatment Business (2016-2021)
Figure 67. Eiken Chemical Revenue Growth Rate in Tuberculosis Diagnosis and Treatment Business (2016-2021)
Figure 68. Epistem Revenue Growth Rate in Tuberculosis Diagnosis and Treatment Business (2016-2021)
Figure 69. Roche Revenue Growth Rate in Tuberculosis Diagnosis and Treatment Business (2016-2021)
Figure 70. GSK Revenue Growth Rate in Tuberculosis Diagnosis and Treatment Business (2016-2021)
Figure 71. Hain Lifesciences Revenue Growth Rate in Tuberculosis Diagnosis and Treatment Business (2016-2021)
Figure 72. Hologic Revenue Growth Rate in Tuberculosis Diagnosis and Treatment Business (2016-2021)
Figure 73. Labatec Revenue Growth Rate in Tuberculosis Diagnosis and Treatment Business (2016-2021)
Figure 74. Lupin Revenue Growth Rate in Tuberculosis Diagnosis and Treatment Business (2016-2021)
Figure 75. Otsuka Novel Products Revenue Growth Rate in Tuberculosis Diagnosis and Treatment Business (2016-2021)
Figure 76. QIAGEN Revenue Growth Rate in Tuberculosis Diagnosis and Treatment Business (2016-2021)
Figure 77. Sandoz Revenue Growth Rate in Tuberculosis Diagnosis and Treatment Business (2016-2021)
Figure 78. Sanofi Revenue Growth Rate in Tuberculosis Diagnosis and Treatment Business (2016-2021)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed